Alessandra Curioni Fontecedro: Giuseppe Curigliano represents ESMO for me
Alessandra Curioni Fontecedro, Head of Medical Oncology at HFR Fribourg – Cantonal Hospital, shared Antonio Passaro’s post, adding: .
“There are moments when you have to take a position, this time was an easy one.
I voted for Giuseppe Curigliano.
Giuseppe Curigliano represents ESMO for me: Science and Education !!
His commitment to our society is extraordinary and he has been an inspiration through years.”
Quoting Antonio Passaro’s post:
“I echo the AIOM (Italian Association for Medical Oncology) and fully support Giuseppe Curigliano for ESMO President 2027-28.
I urge all medical oncologists and ESMO members worldwide to vote for Prof Curigliano.
Every vote counts!!”
Source: Alessandra Curioni Fontecedro/X and Antonio Passaro/X
Antonio Passaro MD PhD, a medical oncologist at the European Institute of Oncology in Milan, specializes in lung cancer research and treatment. he focuses on developing new therapies, including immunotherapy, and identifying reliable biomarkers for non-small cell lung cancer (NSCLC).
Dr. Passaro leads lung cancer trials, evaluates therapeutic efficacy and safety. Authoring over 100 peer-reviewed papers, he also holds editorial positions and key roles in societies like ESMO and AIOM.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023